02 Oct 2024
IMIB- Irraxca, one of the scientific partners of ULISES, participated in this congress presenting the poster communication "Assessment of the efficacy of a monoclonal antibody against pancreatic tumour cells by complement-dependent cytotoxicity assay".
Nanoparticles may be the future of the fight against pancreatic cancer, but also tumours that currently have no cure options. A video news release provides a synthesis of the ULISES project milestones.
In this interview, Victor Pallaruelo, as author of the first ULISES technical project, explains his role in the project.
Eric Spierings, Associate Professor and Medical Immunologist at the University Medical Center of Utrecht, explains to us how his team is contributing to ULISES’ goals in fighting cancer.